Antifungal susceptibility testing of dermatophytes: Development and evaluation of an optimised broth microdilution method
Abstract
Background: Dermatophytosis is one of the most common infections affecting 3%–17% of the population. Resistance to antifungals so far was not of concern in the therapeutic management. However, recent reports of terbinafine‐resistant strains in several countries are worrisome making antifungal susceptibility testing inevitable.Objectives: We aimed to develop and evaluate an optimised broth microdilution assay for antifungal drug susceptibility testing of dermatophytes.Methods: We first studied the effect of different inocula, incubation temperatures and incubation times to establish an optimised assay. Subsequently, we tested 79 clinical strains of 11 dermatophyte species with 13 antifungals.Results: We found inoculating with 0.5–5 × 104 colony forming units (CFU) and incubating at 29°C ± 1°C for 4 days to be appropriate. Terbinafine was the most active antifungal agent with minimum inhibitory concentration (MIC) values ≤ 0.06 µg/mL, expect for one resistant T mentagrophytes strain, which was isolated from an Indian patient. Also, a majority of MICs of other antifungals that are commonly used to treat dermatophytosis were low, except those of fluconazole. Fluconazole MICs do not correlate with the good efficacy in the clinical management.Conclusions: Our assay enables fast and reliable susceptibility testing of dermatophytes with a large panel of different antifungals. This helps to improve the therapeutic management of dermatophytosis by detecting resistant strains.Keywords
This publication has 25 references indexed in Scilit:
- In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, TurkeyInternational Journal of Dermatology, 2013
- Identification and antifungal susceptibility of fungi isolated from dermatomycosesJournal of the European Academy of Dermatology and Venereology, 2013
- Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques forIn VitroDetection of Antifungal Resistance in Yeast IsolatesJournal of Clinical Microbiology, 2010
- In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosisInternational Journal of Antimicrobial Agents, 2007
- Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytesMedical Mycology, 2007
- In vitro methods for antifungal susceptibility testing of Trichophyton spp.Mycological Research, 2006
- Evaluation of Broth Microdilution Antifungal Susceptibility Testing Conditions for Trichophyton rubrumJournal of Clinical Microbiology, 2005
- Collaborative Evaluation of Optimal Antifungal Susceptibility Testing Conditions for DermatophytesJournal of Clinical Microbiology, 2002
- Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenailJournal of the American Academy of Dermatology, 1998
- Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study GroupAntimicrobial Agents and Chemotherapy, 1995